Toxic epidermal necrolysis Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

1Recruiting trials

🩺

12Specialists

Regulatory Watchboard

2 events

Oct 2025New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Hospices Civils de Lyon — PHASE1, PHASE2

TrialNOT YET RECRUITING

Jul 2023Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Peng Zhang — EARLY_PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Toxic epidermal necrolysis.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1EARLY_PHASE1

1Total recruiting

Search clinical trials for Toxic epidermal necrolysis →

Recent News & Research

No recent news articles indexed yet for Toxic epidermal necrolysis.
Search PubMed for Toxic epidermal necrolysis →

Browse all Toxic epidermal necrolysis news →

Specialist Network

Top 6 by expertise

Chun Bing Chen

Chang Gung Memorial Hospital

Score 71 trial891 pubs

Donald T Tan, FRCS

SNEC, SERI, NUS

Score 61 trial

Pinnita Prabhasawat, MD

Mahidol University

Score 63 trials

Leonard P Ang, FRCS

SNEC, NUS

Score 61 trial

Elizabeth J Phillips, MD

Vanderbilt University Medical Center

Score 61 trial

Saskia Oro, PhD

saskia.oro@aphp.fr

Score 41 trial

View all Toxic epidermal necrolysis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰